Full professor
Organizational affiliation: Department of Medicine and Surgery
Translational biomedical sciences Unit
SSD: Human Anatomy (BIOS-12/A)

Contacts

Office: Polo Ospedaliero Universitario - Padiglione 26 - Clinica Medica
Address: via Antonio Gramsci 14, 43126 Parma

Mon-Fry from 9 am - 6 pm

For appoinments, please contact elena.masselli@unipr.it

Curriculum Vitae

Current Position

Associate Professor, SSD BIO/16 (Human Anatomy), Department of Medicine and Surgery– University of Parma

2022 : National Scientific Qualification for Full Professor position in Human Anatomy (SC 05/H1)

 

Education and Training

2007: Medical Degree, 110/110 with honors, University of Parma Medical School, Parma, Italy

2012: Hematology Board, 50/50 with honors, University of Parma, Parma, Italy

2016: PhD degree, Molecular Biology and Pathology, University of Parma, Italy

 

Previous Positions

  • 12/2019-12/2022: Senior Assistant Professor (RTD b) SSD BIO/16 (Human Anatomy), Department of Medicine and Surgery– University of Parma
  • 12/2016-12/2019: Junior Assistant Professor (RTD-a), SSD BIO/16 (Human Anatomy), Department of Medicine and Surgery– University of Parma
  • 04/2016-12/2016: Post-doc fellow, Department of Clinical and Experiment– University of Parma
  • 01/2013/03/2016: PhD student, Department of Biomedical Biotechnological and Translational Sciences – University of Parma
  • 02/2011-08/2011: Post-doc fellow, Tisch Cancer Institute, Div. of Hematology/Medical Oncology, Mount Sinai Medical Center, New York, N.Y. USA
  • 03/2010-02/2011: Visiting Scientist, Assistant Professor, Tisch Cancer Institute, Div. Hematology/Oncology Mount Sinai Medical Center, New York, NY
  • 04/2008-04/2012: Hematology fellow – University of Parma

 

Contribution to Science

Total number of publications on peer-reviwed journals :  38

Total n. of citation: Scopus: 759  

H-index Scopus: 14

 

Prize & Awards

-          2018: Research prize "Il Sorriso di Lella" Foundation for Under40 investigator in Hematology/Oncology of Parma University Hospital

-          2017: Outstanding Abstract Achievement Award, 10th International Congress on Myeloproliferative Neoplasms, New York, November 2017

-          2014: “Luca Buganza Prize” of the Italian Association Against Cancer (LILT)

-          2013: Travel Grant Award for the 7th Biennial International Congress on Myeloproliferative Neoplasms and Myelodysplasia”, Brooklyn, NY, November 2013

-          2013: American Society of Hematology Abstract Achievement Award, ASH 55th Annual Congress. New Orleans, USA December 2013

-          2009: Rotary Foundation Ambassadorial Scholarship, for the Academic Year (AY) 2009/2010

-          2008: Best thesis in Medicine award for the AY 2016/2017

 

Research Activities

Scientific coordiation

2013-2016: Principal Investigator of the project: "Role of PKC in Myeloproliferative Neoplasms”

2019-current: Local Principal Investigator of the project: “Understanding the role of circulating microvesicles in the inflammatory microenvironment of Myeloproliferative Neoplasms”. Promoter: Bologna University Hospital

2020-current: Principal Investigator of the project: “Studio Monocentrico Retrospettivo di correlazione tra parametri emocromocitometrici e outcome nel COVID-19”

2022-current: Principal Investigator of the project: “Establishing the mechanism of chemokine-receptor 2 overexpression in myelofibrosis: paving the way for a novel therapeutic strategy”

 

International collaborations
David Scadden, Massachusetts General Hospital, Boston, USA

Anna Rita Migliaccio & Ronald Hoffman, Mount Sinai Hospital, New York, USA

Joseph E. Italiano, Brigham and Women's Hospital and Harvard Medical School, Boston, USA

Andreas Reiter, Universitätsmedizin Mannheim, Mannheim, Germany

Peter Parker, Francis Crick Institute, London, UK

Steven Sykes, Fox Chase Cancer Center, Philadelphia,USA

 

Funding

-          2021-current: Unit Coordinator of WP2 of the project: “T-cell functional reconstitution by metabolic modulation to treat chronic HBV infection and immunological predictors to optimize therapeutic efficacy” (PI: Prof. C. Ferrari, Dip. Medicina e Chirurgia, Università di Parma). Funding: Ministry of Health, Emilia Romagna Region-University Program (FIN-RER)

-          2022-current: Principal investigator of the project: “Establishing the mechanism of chemokine-receptor 2 overexpression in myelofibrosis: paving the way for a novel therapeutic strategy” funded by University of Parma, Bando di Ateneo per la Ricerca 2021, action B Under40 investigators

-          2022-current: Principal investigator of the project GR-2021-12373308: “A new diagnostic algorithm to non-invasively track fibrotic changes in myeloproliferative neoplasms based on C-C Chemokine Receptor 2 detection. From flow cytometry to the development of targeted Positron Emission Tomography molecular imaging. Pre-clinical studies and first in-human proof of concept”, funded by the Ministry of Health, Bando Ricerca  Finalizzata, action Under40 investigators

 

Member of the Scientific Secretariat 

- the 72nd National Congress of Anatomy and Histology (Parma, Sept. 2018)

- MPN Clinical experience (webinair, June, Sept and Nov 2021)

- La multidisciplinarietà nella policitemia (Parma Oct, 2022)

 

Academic Assignments

Member of the Academic Board of the PhD Program in Molecular Medicine (University of Parma) and of the Fellowship Program in Hematology (University of Parma).

Since 2022: Member of the Review Group (GdR) of the International SINGLE CYCLE DEGREE/COMBINED BACHELOR AND MASTER in Medicine and Surgery (University of Parma).

Since 2022: Erasmus Delegate of the International SINGLE CYCLE DEGREE/COMBINED BACHELOR AND MASTER in Medicine and Surgery (University of Parma).

 

Membership

Member Italian Society of Antomy and Histology (SIAI),  Italian Society of Hematology (SIE), of the Italian Society of Experimental Hematology (SIES), Junior member of the European Hematology Association (EHA)

 

Editorial activity 

Referee per the following journals: Blood (IF 22.113), Blood Advance (6.799), Experimental Hematology (IF 3.084), Cell Death & Disease (IF 8.469), Cytokine (IF 3.861), Lab Investigation (IF 5.662), Frontiers in Oncology (4.848)

2022: Associate editor of the journal Frontiers in Hematology, specialty section “Red Cells, Iron and Erythropoiesis”

2021: Co-guest editor of the Special Issue: “Myeloproliferative Neoplasms: From Genetic Landscape to Therapeutic Targets", Cells (IF 6.600, ISSN: 2073-4409).

Since 2018: Member of REPRISE- Register of Expert Peer Reviewers for Italian Scientific Evaluation per la the section: basic research

Since 2018: Referee ex post for projects of the Italian Ministry of research (FIRB project)

Since 2014: Referee and Editorial Board member of the journal "International Journal of Hematology Research" (ISSN: 2409-3548)

2010-2015: Associate Faculty Member of F1000 – Faculty of 1000 post publication peer reviewer

Teachings

Research

Publications

Research projects

  • Establishing the mechanisms of C-C Chemokine-Receptor 2 (CCR2) overexpression in myelofibrosis: implications for CCL2-mediated disease progression and preclinical validation of CCR2-blockage as a novel therapeutic strategy

    Manager: Masselli Elena

Public Engagement Initiatives

  • Insieme per condividere le malattie mieloproliferative - Seminario pazienti - medici

    L’incontro dedicato ai pazienti ha consentito un momento di confronto su queste patologie, per definire la diagnosi e le terapie possibili anche con la presentazione di farmaci innovativi, ma soprattutto un momento di condivisione della cronicità di malattia e degli aspetti psicologici ad essa correlati.

  • Notte Europea dei Ricercatori, Piacenza

    iniziativa europea di avvicinamento della popolazione, in particolare di bambini e ragazzi, al mondo della scienza

  • Intervento dal titolo "A ciascuno la sua cura. Da dove arriva, e dove va, la medicina personalizzata" c/o Festival del Pensiero Contemporaneo, Piacenza

    Intervento divulgativo aperto alla cittadinanza, moderato da giornalista della durata di circa 1h:30, sul tema della medicina personalizzata.

Loading…